121 related articles for article (PubMed ID: 19052146)
1. Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB.
Healy NC; O'Connor R
J Leukoc Biol; 2009 Mar; 85(3):481-90. PubMed ID: 19052146
[TBL] [Abstract][Full Text] [Related]
2. PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit.
Tanaka T; Grusby MJ; Kaisho T
Nat Immunol; 2007 Jun; 8(6):584-91. PubMed ID: 17468759
[TBL] [Abstract][Full Text] [Related]
3. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.
Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T
Front Immunol; 2020; 11():1559. PubMed ID: 32849529
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappaB.
Takashiba S; Van Dyke TE; Amar S; Murayama Y; Soskolne AW; Shapira L
Infect Immun; 1999 Nov; 67(11):5573-8. PubMed ID: 10531202
[TBL] [Abstract][Full Text] [Related]
5. HSP70 mediates degradation of the p65 subunit of nuclear factor κB to inhibit inflammatory signaling.
Tanaka T; Shibazaki A; Ono R; Kaisho T
Sci Signal; 2014 Dec; 7(356):ra119. PubMed ID: 25515536
[TBL] [Abstract][Full Text] [Related]
6. PDLIM2 protects articular chondrocytes from lipopolysaccharide-induced apoptosis, degeneration and inflammatory injury through down-regulation of nuclear factor (NF)-κB signaling.
Guo Q; Xu J; Shi Q; Wu S
Int Immunopharmacol; 2020 Nov; 88():106883. PubMed ID: 32805696
[TBL] [Abstract][Full Text] [Related]
7. PDLIM1 inhibits NF-κB-mediated inflammatory signaling by sequestering the p65 subunit of NF-κB in the cytoplasm.
Ono R; Kaisho T; Tanaka T
Sci Rep; 2015 Dec; 5():18327. PubMed ID: 26679095
[TBL] [Abstract][Full Text] [Related]
8. PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome.
Bowe RA; Cox OT; Ayllón V; Tresse E; Healy NC; Edmunds SJ; Huigsloot M; O'Connor R
Mol Biol Cell; 2014 Jan; 25(1):184-95. PubMed ID: 24196835
[TBL] [Abstract][Full Text] [Related]
9. Interferon-γ enhances phorbol myristate acetate-induced cell attachment and tumor necrosis factor production via the NF-κB pathway in THP-1 human monocytic cells.
Kurihara Y; Furue M
Mol Med Rep; 2013 Jun; 7(6):1739-44. PubMed ID: 23589028
[TBL] [Abstract][Full Text] [Related]
10. Klotho ameliorates cyclosporine A-induced nephropathy via PDLIM2/NF-kB p65 signaling pathway.
Jin M; Lv P; Chen G; Wang P; Zuo Z; Ren L; Bi J; Yang CW; Mei X; Han D
Biochem Biophys Res Commun; 2017 Apr; 486(2):451-457. PubMed ID: 28315683
[TBL] [Abstract][Full Text] [Related]
11. PDLIM2 acts as a cancer suppressor gene in non-small cell lung cancer via the down regulation of NF-κB signaling.
Shi H; Ji Y; Li W; Zhong Y; Ming Z
Mol Cell Probes; 2020 Oct; 53():101628. PubMed ID: 32621848
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin and protein kinase C regulate PDLIM2 activation and STAT1 ubiquitination in LPS-treated murine macrophages.
Guo H; Mi Z; Bowles DE; Bhattacharya SD; Kuo PC
J Biol Chem; 2010 Nov; 285(48):37787-96. PubMed ID: 20889505
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S
Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486
[TBL] [Abstract][Full Text] [Related]
14. PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer.
Cox OT; Edmunds SJ; Simon-Keller K; Li B; Moran B; Buckley NE; Bustamante-Garrido M; Healy N; O'Flanagan CH; Gallagher WM; Kennedy RD; Bernards R; Caldas C; Chin SF; Marx A; O'Connor R
Cancer Res; 2019 May; 79(10):2619-2633. PubMed ID: 30885980
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines.
Weiss T; Shalit I; Blau H; Werber S; Halperin D; Levitov A; Fabian I
Antimicrob Agents Chemother; 2004 Jun; 48(6):1974-82. PubMed ID: 15155187
[TBL] [Abstract][Full Text] [Related]
16. Kruppel like factor 10 up-regulates PDZ and LIM domain containing protein 2 via nuclear factor kappa-B pathway to inhibit proliferation and inflammatory of fibroblastoid synovial cell in rheumatoid arthritis.
Wang S; Zha X; Ruan S; Yao S; Zhang X
Bioengineered; 2022 Jan; 13(1):1779-1790. PubMed ID: 34713769
[TBL] [Abstract][Full Text] [Related]
17. Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth.
Loughran G; Healy NC; Kiely PA; Huigsloot M; Kedersha NL; O'Connor R
Mol Biol Cell; 2005 Apr; 16(4):1811-22. PubMed ID: 15659642
[TBL] [Abstract][Full Text] [Related]
18. [PDLIM2 and Its Role in Oncogenesis--Tumor Suppressor or Oncoprote?].
Maryáš J; Bouchal P
Klin Onkol; 2015; 28 Suppl 2():2S40-6. PubMed ID: 26374157
[TBL] [Abstract][Full Text] [Related]
19. Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice.
Hao YR; Tang FJ; Zhang X; Wang H
Biochem Biophys Res Commun; 2018 Sep; 503(2):564-571. PubMed ID: 29852170
[TBL] [Abstract][Full Text] [Related]
20. PDLIM2 inhibits T helper 17 cell development and granulomatous inflammation through degradation of STAT3.
Tanaka T; Yamamoto Y; Muromoto R; Ikeda O; Sekine Y; Grusby MJ; Kaisho T; Matsuda T
Sci Signal; 2011 Dec; 4(202):ra85. PubMed ID: 22155789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
